Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Pediatric Statin Administration: Navigating a Frontier with Limited Data.

Wagner J, Abdel-Rahman SM.

J Pediatr Pharmacol Ther. 2016 Sep-Oct;21(5):380-403. Review.

2.

Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study.

Khalilieh S, Yee KL, Sanchez RI, Triantafyllou I, Fan L, Maklad N, Jordan H, Martell M, Iwamoto M.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01364-16. doi: 10.1128/AAC.01364-16. Print 2017 Feb.

3.

Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients.

Ye YC, Zhao XL, Zhang SY.

Chin Med J (Engl). 2015 Jan 20;128(2):259-66. doi: 10.4103/0366-6999.149226. Review.

4.

Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.

Abbas A, Milles J, Ramachandran S.

Clin Med Insights Endocrinol Diabetes. 2012;5:13-30. doi: 10.4137/CMED.S7591. Epub 2012 Feb 20.

5.

Randomized Polypill crossover trial in people aged 50 and over.

Wald DS, Morris JK, Wald NJ.

PLoS One. 2012;7(7):e41297. doi: 10.1371/journal.pone.0041297. Epub 2012 Jul 18.

6.

Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells.

Aprigliano I, Dudas J, Ramadori G, Saile B.

Liver Int. 2008 Apr;28(4):546-57. doi: 10.1111/j.1478-3231.2008.01682.x.

7.

Courting hyperlipidemia.

Parmar MS.

CMAJ. 2004 Jan 6;170(1):13. No abstract available.

8.

Taking simvastatin in the morning compared with in the evening: randomised controlled trial.

Wallace A, Chinn D, Rubin G.

BMJ. 2003 Oct 4;327(7418):788. No abstract available.

Supplemental Content

Support Center